Public-registry site landscape for NCT07742215, a Myeloma Multiple study sponsored by Biocad. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07742215 (registry record) |
| Sponsor | Biocad |
| Condition(s) | Myeloma Multiple |
| Phase | PHASE3 |
| Listed sites | 16 |
| Site countries | Belarus, Russia |
Eichor generates a preliminary site-risk snapshot for NCT07742215 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →